F. Lara‐Villoslada

Newbiotechnic (Spain)

Health Outcomes Studied

• Enhanced Natural Killer Cell Tumoricidal Activity
• Improved Bowel Movement Frequency
• Improved Gut Microbiota
• Increased Fecal Butyrate Levels
• Increased Fecal Lactobacilli
• Increased IL-12 Levels
• Increased Interleukin-10 Levels
• Increased Plasma Immunoglobulin Levels
• Increased Stool Volume

Papers (8)

• 2012
  Human Milk Probiotic Lactobacillus fermentum CECT5716 Reduces the Incidence of Gastrointestinal and Upper Respiratory Tract Infections in Infants10.1097/MPG.0b013e3182333f18
• 2012
  Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial.10.1016/j.phrs.2011.11.016
• 2010
  Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults.10.1016/j.anaerobe.2010.02.001
• 2010
  Safety and tolerance of the human milk probiotic strain Lactobacillus salivarius CECT5713 in 6-month-old children.10.1016/j.nut.2009.08.023
• 2009Primary author
  Safety Assessment of Lactobacillus fermentum CECT5716, a probiotic strain isolated from human milk10.1017/S0022029909004014
• 2007
  Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination.10.1016/J.NUT.2007.01.004
• 2007Primary author
  Safety assessment of the human milk-isolated probiotic Lactobacillus salivarius CECT5713.10.3168/JDS.2006-685
• 2006
  Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.10.1016/J.IJFOODMICRO.2005.08.019